JANUS HENDERSON GROUP PLC

Position in ERAS — Erasca, Inc.

CIK 1274173 LONDON, X0

Position in ERAS

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$60,043,429

+$59,943,145 QoQ

Shares Held

3,710,966

+4969.6% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 97.93584743163909.ToString("F0")% None 2.0641525683609068.ToString("F0")%

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,891,244,813 across 182 Biotechnology names. ERAS ranks #48 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,541,732	$1,856,099,791
2	PRAX	Praxis Precision Medicines, Inc.	3,458,863	$1,114,411,067
3	MDGL	Madrigal Pharmaceuticals, Inc.	2,018,647	$1,056,701,142
4	BBIO	BridgeBio Pharma, Inc.	13,179,013	$978,673,503
5	PCVX	Vaxcyte, Inc.	16,575,875	$963,224,094
6	VRTX	Vertex Pharmaceuticals Inc / Ma	2,131,527	$951,812,064
7	RVMD	Revolution Medicines, Inc.	9,766,496	$949,791,733
8	MIRM	Mirum Pharmaceuticals, Inc.	6,945,813	$641,654,204

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$60,043,429	3,710,966	+4969.6%	Shares	Defined	2026-05-18
2025-03-31	$100,284	73,200	0.0%	Shares	Defined	2025-05-15
2024-12-31	$183,732	73,200	-98.2%	Shares	Defined	2025-02-14
2024-09-30	$11,219,066	4,109,548	-49.7%	Shares	Defined	2024-11-14
2024-06-30	$19,300,297	8,178,092	+19974.4%	Shares	Defined	2024-08-14
2023-12-31	$86,773	40,739	-0.0%	Shares	Defined	2024-02-14
2023-09-30	$80,269	40,746	+0.0%	Shares	Defined	2023-11-14
2023-06-30	$112,455	40,745	+0.2%	Shares	Defined	2023-08-14
2023-03-31	$122,404	40,666	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.